In response to ionizing radiation, the MRE11/RAD50/NBN complex re-distributes to the sites of DNA double-strand breaks (DSBs) where each of its individual components is phosphorylated by the serine-threonine kinase, ATM. ATM phosphorylation of NBN is required for the activation of the S-phase checkpoint, but the mechanism whereby these phosphorylation events signal the checkpoint machinery remains unexplained. Here, we describe the use of direct protein transduction of the homing endonuclease, I-PpoI, into human cells to generate site-specific DSBs. Direct transduction of I-PpoI protein results in rapid accumulation and turnover of the endonuclease in live cells, facilitating comparisons across multiple cell lines. We demonstrate the utility of this system by introducing I-PpoI into isogenic cell lines carrying mutations at the ATM phosphorylation sites in NBN and assaying the effects of these mutations on the spatial distribution and temporal accumulation of NBN and ATM at DSBs by chromatin immunoprecipitation, as well as timing and extent of DSB repair. Although the spatial distribution of NBN and ATM recruited to the sites of DSBs was comparable between control cells and those expressing phosphorylation mutants of NBN, the timing of accumulation of NBN and ATM was altered. Serine-to-alanine mutations that blocked phosphorylation resulted in delayed recruitment of both NBN and ATM to DSBs. Serine-to-glutamic acid substitutions that mimicked the phosphorylation event resulted in both increased and prolonged accumulation of both NBN and ATM at DSBs. The repair of DSBs in cells lacking full-length NBN was significantly delayed compared with control cells, whereas blocking phosphorylation of NBN resulted in a more modest delay in repair. These data indicate that following the induction of DSBs, phosphorylation of NBN regulates its accumulation, and that of ATM, at sites of DNA DSB as well as the timing of the repair of these sites. Effects of NBN phosphorylation mutants J Wen et al Effects of NBN phosphorylation mutants J Wen et al Supplementary Information accompanies the paper on the Oncogene website (http://www.nature.com/onc) Effects of NBN phosphorylation mutants J Wen et al
INTRODUCTION
Nijmegen breakage syndrome (NBS) is a rare autosomal recessive disorder characterized by growth retardation, microcephaly, immunodeficiency and elevated cancer incidence. [1] [2] [3] NBS results from biallelic hypomorphic mutations in the NBN gene, which encodes the 754 amino-acid protein, Nibrin. [3] [4] [5] The majority of NBS patients have truncating mutations in both alleles of the NBN gene. As a result, their cells fail to make detectable full-length NBN but can produce varying amounts of truncated fragments from the amino and carboxy terminal ends of the protein. 6, 7 In vitro, cells from NBS patients display impaired survival and an inability to activate the S-phase checkpoint after exposure to agents, such as ionizing radiation, that generate DNA double-strand breaks (DSBs). 8, 9 These phenotypes are also observed in cells from patients with Ataxia-Telangiectasia (A-T), which arises from deleterious mutations in the serine-threonine kinase ATM. 10 NBN associates constitutively with the MRE11 and RAD50 proteins to form the MRE11/RAD50/NBN (MRN) complex. 4, 11 Knockouts of any of the components of the MRN complex in mice lead to early embryonic lethality, [12] [13] [14] reflecting the essential role of this complex in DNA replication. Although MRE11 and RAD50 have predominant enzymatic roles in the complex, NBN has a primarily regulatory role, directing the nuclear localization of the complex, re-distribution of the complex to DSBs upon exposure to DNA-damaging agents, and stimulating the activities of the other components. [15] [16] [17] [18] [19] The MRN complex associates with DNA DSBs within minutes following their formation, 20, 21 and contributes to recruitment of ATM to DNA DSBs through direct protein-protein interaction between ATM and the C-terminal end of NBN. 22, 23 ATM becomes activated in the presence of DNA DSBs and phosphorylates a large number of substrates, some of which, similar to the components of the MRN complex, accumulate at the sites of DSBs. [24] [25] [26] [27] [28] ATM phosphorylates NBN on as many as three serine residues (positions 278, 343 and 397) in response to DNA damage. [29] [30] [31] [32] Alanine substitutions at any one of these positions partially abrogate the S-phase cell cycle checkpoint, resulting in a phenotype of radio-resistant DNA synthesis. 33 However, the precise mechanism by which phosphorylation at these sites signals to the checkpoint machinery remains unknown.
In the current study, we utilize I-PpoI, a eukaryotic homing endonuclease, to create DNA DSBs at defined endogenous sites in isogenic cell lines bearing different mutations at the phosphorylation sites in NBN, allowing us to track and compare protein recruitment and loss at or around these breaks by chromatin immunoprecipitation (ChIP) while also monitoring the repair of DSBs via quantitative PCR. Our data indicate that NBN phosphorylation regulates the stabilization and/or accumulation of NBN or ATM at the sites of DSBs as well as the timing of repair at these sites.
RESULTS
Purified I-PpoI can be efficiently delivered to cells by protein transduction Berkovich et al. 34 previously described a human cell line engineered to express a tamoxifen-regulated version of I-PpoI allowing the induction of DNA DSBs at I-PpoI sites on chromosomes 1 and 8 and characterization of the DNA damage response at these sites by ChIP. To facilitate the comparison of the I-PpoI response across multiple cell lines, and limit the length of exposure of cells to the nuclease, we developed a protein transduction approach for the expression of I-PpoI in human cells using cell-penetrating peptides (CPP). 35, 36 CPP have been shown to deliver a range of different cargoes, including proteins, drugs, nucleic acids and imaging reagents to a wide array of cell types with generally high efficiency, potentially allowing the application of I-PpoI to a variety of different cell lines. A gene encoding I-PpoI was chemically synthesized, cloned, and its protein product was affinity-purified from Escherichia coli ( Figure 1a ). Overnight incubation of purified I-PpoI with a linearized plasmid containing the 15 bp I-PpoI recognition sequence confirmed the activity and specificity of the enzyme and the absence of other significant endonuclease activities (Figure 1b ). CPP incorporating a nuclear localization signal were then used to introduce the purified I-PpoI into an SV40-transformed fibroblast cell line from an NBS patient (NBS-ILB1 cells) 37 stably transfected with either the wild-type NBN gene (ILB1-[NBN] cells), NBN with alanine substitutions at S278 Figure 1 . I-PpoI protein purification and transduction into human cells. (a) I-PpoI protein purified from E. coli was detected by Coomassie staining. (b) pcDNA3.1 containing a synthetic I-PpoI site was linearized by PvuI digestion, and incubated with either control (Con) protein (produced from pET45b( þ ) empty vector-transformed cells) or purified I-PpoI protein at 37 1C overnight. Products were separated on agarose gel. (c) ILB1, ILB1-[NBN] or ILB1-[NBN-S4A] cells were transduced with purified I-PpoI protein complexed with CPP. Cells were collected at 0, 1, 2, 3 and 5 h after transduction. Total protein lysate was separated on a 4-12% gradient Bis-Tris gel, transferred to immobilon-P transfer membrane and immunoblotted with a monoclonal anti-His antibody and a monoclonal anti-tubulin antibody, respectively. (d) ILB1-[NBN] cells were transduced with purified I-PpoI protein complexed with CPP. Cells were collected at 0, 1, 3 and 5 h after transduction. Cytoplasmic and nuclear fractions were prepared and separated on a 4-12% gradient Bis-Tris gel, transferred to immobilon-P transfer membrane and immunoblotted with anti-His antibody, anti-Hsp90 (as a cytoplasmic control) and anti-p84 (as a nuclear control). and S343 (ILB1-[NBN-S4A] cells) or the empty retroviral vector (ILB1 cells). I-PpoI protein of the expected molecular weight was detected in each of these cell lines as early as 1 h post transduction ( Figure 1c ) and localized predominantly to the nucleus at all time points tested ( Figure 1d ). No significant differences between cell lines were observed in the uptake or subsequent loss of I-PpoI by western blot.
Transduced I-PpoI induces site-specific DNA cleavage in vivo A BLAST search of the human genome reference sequence (hg19) identified 10 sites of sequence identity to the I-PpoI restriction site. In addition to the previously reported sites on chromosome 1 within the DAB1 gene and chromosome 8 within the ribosomal DNA cluster, 34 sites were identified on chromosome 1, 2, 3, 7, 11, X, Y and in an unaligned segment. To assess the activity of transduced I-PpoI, ILB1-[NBN] cells were transduced with I-PpoI and quantitative PCR was performed with primers spanning each of these putative cleavage sites. The yield of PCR product from each of these sites at different time points post transduction was compared with that from a reference sequence that did not contain an I-PpoI site (Figure 2a ). In three independent experiments, 8 of the 10 sites displayed cutting upon transduction with I-PpoI, as evidenced by yields o100%, but the maximum cutting never exceeded 30% for any site. previously described, 38 expressed NBN with S4A mutations at positions 278 and 343. ILB1-[NBN-S4E], newly generated for the current study, expressed NBN with S4E mutations at positions 278, 343 and 397. The 411BRneo cell line lacks detectable ligase IV activity due to a homozygous missense mutation at a highly conserved residue (R278H). 39 If the limited cleavage by I-PpoI observed is the result of repair of these sites by non-homologous end-joining, then the 411BRneo cells might be expected to display enhanced cutting in this assay. However, the cutting by I-PpoI in 411BRneo cells was not significantly greater than what was observed in any of the ILB1-derived cell lines, although repair was not complete even 24 Activated ATM phosphorylates histone H2AX at the sites of DNA damage forming gH2AX. 40 
ATM phosphorylation of NBN facilitates its accumulation at sites of DNA damage
To assess the role of ATM phosphorylation of NBN on the timing and spatial distribution of its accumulation at DNA DSBs, two different transfected versions of ILB1 cells were utilized, ILB1-[NBN-S4A] and ILB1-[NBN-S4E] cells. In comparison with ILB1 cells transfected with a wild-type NBN construct, both cell lines expressed comparable levels of NBN and neither was significantly impaired in survival following exposure to ionizing radiation ( Supplementary Figures 1 and 2) . To assay the recruitment and distribution of proteins at and around a site-specific DSB in these cell lines, we utilized pairs of primers for ChIP analysis spaced up to 20 kb on either side of the I-PpoI site located within the DAB1 gene on chromosome 1 and assayed for protein accumulation from 1 to 8 h after treatment of cells with I-PpoI. In ILB1 cells, NBN could not be detected by ChIP at any time point (Figure 4a , first panel). In ILB1-[NBN] cells, NBN was detected at the cleavage site within 1 h after transduction, peaking at 3 h and then decreasing by 5 h. At later time points, the accumulation of NBN shifted to sites from 3 to 10 kb flanking the DSB (Figure 4a, second panel) . In ILB1-[NBN-S4A] cells, the accumulation of NBN at the cleavage site was delayed relative to wild type, peaking at 5 h followed by the normal decline and shift to distal sites by 8 h (Figure 4a , third panel). In ILB1-[NBN-S4E] cells, the accumulation of NBN at the cleavage site was comparable to wild type at the 3 h time point but then failed to resolve, continuing to increase until a broad accumulation of NBN at, and around the cleavage site was apparent at the latest time point, 8 h (Figure 4a , fourth panel).
As ATM recruitment to the sites of DNA damage is stimulated at early times after DNA damage induction by its interaction with the carboxy terminal end of NBN, 23 the ChIP assay was also used to examine ATM protein recruitment to the I-PpoI cut site. Although NBN accumulated directly at the DNA DSB site, ATM was detected in regions of 3-10 kb flanking the site, similar to the accumulation of NBN after 5 h (Figure 4b ). In ILB1 cells there was a very modest increase in the amount of ATM present at these sites over time, consistent with the evidence that NBN stimulates the activation of ATM but is not obligatory for its activation (Figure 4b Although ATM accumulation at the site of the induced DNA DSB was altered in ILB1-[NBN-S4A] and ILB1-[NBN-S4E] cells, the amount of activated ATM in the cells, assayed by phosphorylation on S1981, was generally indistinguishable from that in ILB1-[NBN] cells at 1, 3 and 8 h (Figure 5a ), with the possible exception of a slightly elevated basal level of S1981 phosphorylation in the ILB1-[NBN-S4E] cells. Phosphorylation of CHEK2 on T68 46 at the same time points was indistinguishable from wild type (Figure 5b ). An additional substrate, SMC1, which is phosphorylated by ATM on S957, 44 phosphorylation in the ILB1-[NBN-S4E] cells was increased at the 1 h time point relative to the other cell lines (Figure 5c ).
DISCUSSION
The exact role of ATM phosphorylation of NBN in the DNA damage response remains unresolved. Serine-to-alanine substitutions at the known ATM phosphorylation sites on NBN have, at best, only modest effects on cell survival after irradiation. 29, 31, 32, 47 These mutations do confer a phenotype of radio-resistant DNA synthesis but the mechanism whereby phosphorylation on these residues signals to the S-phase checkpoint machinery has not been elucidated. There is no evidence for modification-dependent protein interactions at the residues on NBN that are phosphorylated by ATM.
In the current study, we examined the spatial orientation and timing of recruitment of NBN and ATM to the sites of DNA breaks induced in isogenic cell lines expressing no full-length NBN, wildtype NBN or NBN in which the ATM phosphorylation sites had been mutated to alanine or glutamic acid in order to determine whether there were features of the spatio-temporal response to DNA damage that were dependent upon ATM-mediated phosphorylation of NBN. Prior studies have explored this issue using laser micro-irradiation in live cells followed by confocal microscopy. 20, 48, 49 To obtain a higher level of resolution than available via microscopy, we adopted a restriction enzyme-driven ChIPbased approach. The approach of using restriction endonucleases, such as I-PpoI used here, to induce DNA DSBs in mammalian cells and the subsequent application of ChIP to these sites is not novel, 34, 50, 51 be induced in transfected cells with tamoxifen, to demonstrate the recruitment of ATM and NBN to the I-PpoI site on chromosome 1 and the concomitant loss of histone H2B at this site.
In the approach described here, we employ CPPs to introduce bacterially produced and epitope-tagged I-PpoI protein into human cells bearing different site-specific mutations in DNA damage response genes. We demonstrate that under the conditions utilized, the majority of cells (490%) are transduced with the protein, incur site-specific DNA DSBs and initiate a normal DNA damage response to the presence of these DSBs. Eight of 10 putative I-PpoI restriction sites identified in the human genome by sequence analysis displayed evidence of cutting by the exogenously introduced endonuclease. Upon transduction of cells with I-PpoI complexed with CPPs, site-specific cleavage of DNA was detected 1 h after transduction (the earliest time point assayed) and was fully repaired within 8 h. Although the majority of cells treated with I-PpoI incur some DNA DSBs, as evidenced by positive staining for gH2AX, the maximum cutting, per individual site, did not exceed 30%. Mutations in proteins involved in DNA damage sensing or repair affected the time to complete repair but not the maximum cutting, suggesting that repeated cycles of cutting and repair were probably not a major factor in determining maximum cutting level. In I-PpoI-transduced ILB1-[NBN] cells the profile of endonucleolytic cutting and repair tracked slightly behind the measures of I-PpoI levels, which peaked at 1 h and declined thereafter. Only limited amounts of I-PpoI were detected after 5 h by immunoblot or immunofluorescence. In ILB1 cells that lack fulllength NBN, and in 411BRneo cells that lack ligase IV, repair was significantly delayed. ILB1 cells ultimately rejoined the induced DSBs, whereas in 411BRneo cells more than half of the cut sites remained unrepaired after 24 h.
The different genomic sites tested in the cutting assay include sites within genes and in intergenic and even highly repetitive regions, which are likely to differ in chromatin configuration. We observed no consistent differences between, for example, genic and intergenic sites, in the maximum levels of cutting attained, but the variability between different cut sites suggests that the role of chromatin in this process bears further investigating. We also observed similar results in cell lines of different origins, such as HEK293 cells or B-lymphoblastoid cells. It is possible that preparations of the I-PpoI enzyme with varying specific activities may differ in the maximum extent of cutting, but, to date, we have observed no significant differences among the preparations we have made (data not shown).
To explore the effects of ATM phosphorylation of NBN on the accumulation of these proteins at the sites of DNA DSBs, we applied the I-PpoI transduction system to two mutant cell lines, ILB1-[NBN-S4A] cells, a previously described cell line with serineto-alanine substitutions at ATM phosphorylation sites in NBN, and ILB1-[NBN-S4E] cells, a new line in which these residues were changed to glutamic acid to mimic constitutive phosphorylation. We observed significant effects on both the timing of repair and the accumulation of ATM and NBN at I-PpoI sites in these mutants, but these effects did not result in impaired survival in clonogenic assays. In ILB1-[NBN-S4A] cells the time course of repair of I-PpoIinduced DNA DSBs was delayed at 5 h relative to that observed in In general, the spatial distribution of NBN and ATM at the DSB site in our ChIP assays was indistinguishable in ILB1 cells complemented with wild-type NBN and the S4A or S4E mutant, as was the extent of ATM activation; it was only the timing of accumulation that was affected. This spatial pattern of NBN and ATM accumulation was also consistent with that observed by Berkovitch et al., 34 although it is unclear how well the time points at which observations were made in the two different systems correspond. Our results indicate that the main effect of ATM phosphorylation of NBN is to stabilize the protein at the site of the DSB leading to its accumulation and that of ATM. In the absence of phosphorylation, both NBN and ATM still accumulate but with slower kinetics. When phosphorylation of NBN is enhanced via phospho-mimic amino-acid substitutions, accumulation of both NBN and ATM at the DSB site is similarly enhanced, in particular by the failure of these proteins to dissociate from the site in a timely fashion, as observed in cells expressing wild-type NBN. Paradoxically, this enhanced accumulation is associated with delayed repair of the site. However, based upon observations of the timing of accumulation of XRCC4 at the sites of DSBs, Berkovich et al. 34 speculated that it was necessary for repair proteins to displace signaling proteins, such as ATM, from the cut site at late time points in order to carry out repair. It is tempting to speculate that the mutant form of NBN in ILB1-[NBN-S4E] cells, whose dissociation from the site is impaired, may hinder access of repair proteins to the DSB and thus, delay repair. A major benefit of the ChIP system described here is that the effects of mutations such as this on the spatio-temporal features of the cellular response to DNA DSBs are both readily observable and comparable between cell lines even in cases where classical assays, such as clonogenic survival, cannot discriminate between the different mutant cell lines.
MATERIALS AND METHODS

Protein purification
I-PpoI open-reading frame was chemically synthesized (GenScript USA Inc., Piscataway, NJ, USA) and cloned into the pUC57 vector. The insert was excised with NotI and XhoI and ligated into a compatible vector, pET45b ( þ ) (Novagen, EMD Chemicals Inc., Gibbstown, NJ, USA). This resulted in the addition of a 6-histidine epitope tag to the N-terminus of the I-PpoI open-reading frame, and brought its expression under the control of a T7 RNA polymerase. I-PpoI protein expression was induced by isopropyl-b-D-thiogalactopyranoside (IPTG) (Fisher Scientific, Pittsburgh, PA, USA) in E. coli strain BL21-DE3 (Novagen). Cultures were allowed to grow 6-8 h at 37 1C, and then lysed in lysis buffer. The cell lysate was stored in À 80 1C overnight and thawed on ice before protein purification. The lysate was then passed through French Press Cell Disruptor (SLM Instruments, Rochester, NY, USA) twice and cell debris was removed by centrifugation. The resulting supernatant was incubated with Ni-NTA beads (Qiagen Inc., Valencia, CA, USA) for 30 min with agitation at 4 1C, then loaded onto a poly-prep chromatography column (Bio-Rad, Hercules, CA, USA). The protein was eluted by an increasing gradient of imidazole (Fisher). The fractions containing I-PpoI were pooled together and dialyzed overnight at 4 1C. Protein concentration was determined using Bio-Rad protein assay (Bio-Rad). Purified protein was resolved on a NuPAGE gradient 4-12% Bis-Tris Gel (Invitrogen, Grand Island, NY, USA) and stained using EZBlue Gel Staining Reagent (Sigma-Aldrich Product, St Louis, MO, USA). Cell culture and protein transduction All ILB1-derived cells were grown in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum (FBS), 1% pen/strep, 1% nonessential amino acid (NEAA), 1% sodium pyruvate and 0.5 mg/ml geneticin. 411BRneo cells were cultured in minimum essential medium supplemented with 15% FBS, 1% pen/strep, 1% NEAA and 1% sodium pyruvate. HEK293T cells were cultured in Dulbecco's modified Eagle's medium supplemented with 10% FBS, 1% pen/strep, 1% NEAA and 1% sodium pyruvate. BLCL-309 cells were cultured in minimum essential medium with 10% FBS, 1% pen/strep, 1% NEAA and 1% sodium pyruvate. For all experiments, cells were maintained at 37 1C in 5% CO 2 /95% air. I-PpoI protein was introduced into target cell lines using either CPP, Pep-1, (AnaSpec, Fremont, CA, USA) or protein delivery reagent, Chariot (Active Motif, Carlsbad, CA, USA). No significant differences were observed between the transfection efficiency of Pep-1 and Chariot. I-PpoI protein transfection was performed according to the manufacturer's instructions. First, I-PpoI protein was diluted in phosphate-buffered saline (PBS) and Pep-1/chariot was diluted in sterile water. Then the diluted I-PpoI was added to the diluted Pep-1/chariot and incubated at room temperature for 30 min to allow the protein/CPP complex to form. Before transfection, cells were washed once with PBS and overlaid with I-PpoI/CPP complex. Serumfree medium was added to the cell culture, which was then incubated at 37 1C for at least 1 h.
DNA cleavage assay
Cells were grown in 10-cm dishes to B95% confluence. After I-PpoI protein transduction, cells were washed twice with ice-cold PBS and harvested in ice-cold PBS containing protease inhibitors (Roche Diagnostics, Indianapolis IN, USA). After centrifugation at 3000 r.p.m. for 5 min, the supernatant was removed and cells were resuspended in ChIP sonication buffer containing protease inhibitors, incubated on ice for 10 min, and subjected to sonication using a Branson Sonifier 250 (Branson Ultrasonics, Danbury, CT, USA) at output 8.0 and 80% cycle duty for 90s. After sonication, cell suspensions were centrifuged at 13 000 r.p.m. for 15 min, and supernatant was collected as whole-cell extracts (WCEs). DNA was extracted from equal amount of WCE using PCR purification kit (Qiagen). Aliquots (5 ml) were used for each real-time PCR reaction with primers spanning each of the putative I-PpoI cleavage sites and a reference sequence that did not contain an I-PpoI site. Primer sequences are provided in Supplementary Table 1 . PCR results were analyzed by comparing the yield of PCR product from each of these sites at different time points post transduction with that from the reference sequence. C t values were calculated and represented as a percentage of uncut I-PpoI sites. Experiments were repeated three times, and the error bars represent mean ± s.d.
Immunoblotting and immunoprecipitation
For immunoblotting, cells were lysed in SDS lysis buffer with protease and phosphatase inhibitors (Roche). Nuclear and cytoplasmic extracts were prepared using NE-PER Nuclear and Cytoplasmic Extraction Reagents (Thermo Scientific, Rockford, IL, USA). Protein concentration was determined using Bio-Rad protein assay (Bio-Rad). Whole-cell lysates or nuclear extracts containing 50 mg of protein were separated on gradient NuPAGE (3-8% Tris-Acetate or 4-12% Bis-Tris) Gels (Invitrogen) and transferred to Immobilon-P transfer membranes (Millipore Corporation, Billerica, MA, USA) for antibody probing. For immunoprecipitation, cells were lysed in EBC buffer with protease and phosphatase inhibitors. Lysates containing 500 mg of protein were incubated with indicated antibody overnight at 4 1C, and protein G agarose (Santa Cruz Biotechnology, Santa Cruz, CA, USA) was added for an additional 1 h at 4 1C. Agarose pellets were washed three times in EBC buffer, and the bound proteins were removed by boiling in lithium dodecyl sulfate (LDS) buffer (Invitrogen). Eluted proteins were then separated on a 3-8% Tris-Acetate gel and transferred to Immobilon-P transfer membrane for antibody probing. Antibodies used were: anti-ATM (Genetex Inc., Irvine, CA, USA), anti-ATMSer1981p (Rockland Immunochemicals Inc., Gilbertsville, PA, USA), anti-NBN (Novus Biologicals, Inc., Littleton, CO, USA), anti-NBNSer343p (Upstate Cell Signaling Solutions, Lake Placid, NY, USA), anti-gH2AX (Millipore), anti-His (GE Healthcare, Piscataway, NJ, USA), anti-tubulin (Sigma-Aldrich Product), anti-CHK2Thr68p (Cell Signaling Technology, Danvers, MA, USA), anti-CHK2 (Novus Biologicals, Inc.), anti-SMC1Ser957p (Cell Signaling Technology), anti-SMC1 (Bethyl Laboratories Inc., Montgomery, TX, USA), anti-Hsp90 (Cell Signaling Technology) and anti-p84 (Genetex).
Immunofluorescence microscopy
Cells were grown in a 4-well chamber slide system (Nalge Nunc International, Naperville, IL, USA) to 50% confluence. After transfection, cells were fixed in 4% paraformaldehyde solution (Electron Microscopy Sciences, Hatfield, PA, USA) for 20 min at room temperature, followed by 5 min permeabilization in 0.4% Triton X-100 solution (Sigma-Aldrich Product). After blocking in 10% bovine serum albumin/PBS at 37 1C for 30 min, cells were incubated with anti-gH2AX antibody (Millipore) at 4 1C overnight followed by incubation with Alexa Fluor 488-labeled anti-mouse antibody (Invitrogen) at room temperature for 1 h. Slides were removed from chamber and air-dried in dark for 5 min before mounting with Vectashield Mounting Medium (with 4',6-diamidino-2-phenylindole) (Vector Laboratories, Inc., Burlingame, CA, USA).
ChIP assay
Cells were grown in 15-cm dishes to B95% confluence. After protein transduction, cells were cross-linked with 1% formaldehyde for 10 min at 37 1C. Cross-linking was quenched by adding glycine to a final concentration of 0.125 M. Cells were washed twice with ice-cold PBS and harvested in ice-cold PBS containing protease inhibitors. After centrifugation at 3000 r.p.m. for 5 min, the supernatant was removed and cells were resuspended in ChIP sonication buffer containing protease inhibitors, incubated on ice for 10 min, and then subjected to sonication using a Branson Sonifier 250 at an output of 3.0. Twenty-five cycles of 5 s pulses were administered to shear chromatin to 700-1000 bp fragments. The effectiveness of shearing was confirmed by testing DNA aliquot on agarose gel. After sonication, cell suspensions were centrifuged at 13 000 r.p.m. for 15 min, and supernatant was collected as WCEs. WCEs (0.2 ml, corresponding to B3 Â 10 6 cells) were diluted to 1 ml in ChIP sonication buffer and then incubated with either no antibody or antibodies targeting ATM or NBN. Another 0.2 ml of the WCE was saved for later standard curve analysis. Incubations occurred overnight at 4 1C with agitation. The next morning 45 ml of protein G-agarose slurry (Santa Cruz Biotechnology) was added and incubated for another 2 h at 4 1C with agitation. The agarose beads were washed three times with ChIP sonication buffer and twice with TE buffer. DNA and protein were eluted from the pellets by incubating the pellets with 100 ml of elution buffer. Cross-linking was reversed by incubating at 65 1C for overnight. DNA fragments were extracted using PCR purification kit (Qiagen). Aliquots (5 ml) were used for each real-time PCR reaction to quantitate immunoprecipitated fragments. PCR results were analyzed from standard curve generated by input dilutions: from 100 to 0.0064%. Results indicate the average from three individual experiments. Primer sequences are provided in Supplementary Table 1 .
